Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 17Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 17Congenital Abnormalities 17Breast Neoplasms 16Lymphoma, Mantle-Cell 15Leukemia 15Lymphoma, Non-Hodgkin 14Lymphoma, Large B-Cell, Diffuse 14Multiple Myeloma 12Lymphoma, Large-Cell, Immunoblastic 11Lymphoma 11Burkitt Lymphoma 11Blast Crisis 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Sezary Syndrome 9Mycosis Fungoides 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large-Cell, Anaplastic 8Hodgkin Disease 8Primary Myelofibrosis 7Pdgfra-Associated Chronic Eosinophilic Leukemia 6Neoplasms, Plasma Cell 6

Interventions

Etoposide 154Carboplatin 142Cisplatin 104Topotecan 74durvalumab 48atezolizumab 46Irinotecan 44pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 29anlotinib 23PM 01183 22Gemcitabine 21Drug Therapy 20apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Bevacizumab 13amrubicin 11Magnetic Resonance Spectroscopy 11Cyclophosphamide 11rovalpituzumab tesirine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Small Cell Lung Carcinoma × Flow Cytometry × Clear all
NCT00388089 2010-06-29

Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

University of California, Davis

Phase 1 Completed
24 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡